SANTA CLARA , Calif., Oct. 30, 2024 /PRNewswire/ -- Invenio Imaging, a leader in intraoperative fresh tissue imaging and artificial intelligence (AI), announced today that the U.S Food and Drug Administration (FDA) has granted Breakthrough Device Designation for the NIO® Lung Cancer...
Invenio Imaging Receives FDA Breakthrough Device Designation for AI-based Image Analysis Module to Assist Physicians in the Evaluation of Bronchoscopic Lung Biopsies
Seaking AlphaSeeking Alpha / Seaking Alpha 7 hours ago 1 Views
Comments